Cargando…

Addressing COVID-19 vaccine hesitancy

Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassianos, George, Puig-Barberà, Joan, Dinse, Hannah, Teufel, Martin, Türeci, Özlem, Pather, Shanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225513/
https://www.ncbi.nlm.nih.gov/pubmed/35814493
http://dx.doi.org/10.7573/dic.2021-12-3
_version_ 1784733631722291200
author Kassianos, George
Puig-Barberà, Joan
Dinse, Hannah
Teufel, Martin
Türeci, Özlem
Pather, Shanti
author_facet Kassianos, George
Puig-Barberà, Joan
Dinse, Hannah
Teufel, Martin
Türeci, Özlem
Pather, Shanti
author_sort Kassianos, George
collection PubMed
description Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine hesitancy. Factors that influence vaccine decision-making are heterogenous, complex, and context specific and may be caused or amplified by uncontrolled online information or misinformation. With respect to COVID-19, the recent emergence of novel variants of concern that give rise to milder disease also drives vaccine hesitancy. Healthcare professionals remain one of the most trusted groups to advise and provide information to those ambivalent about COVID-19 vaccination and should be equipped with adequate resources and information as well as practical guidance to empower them to effectively discuss concerns. This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination.
format Online
Article
Text
id pubmed-9225513
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioExcel Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-92255132022-07-08 Addressing COVID-19 vaccine hesitancy Kassianos, George Puig-Barberà, Joan Dinse, Hannah Teufel, Martin Türeci, Özlem Pather, Shanti Drugs Context Review Immunization programmes have been globally recognized as one of the most successful medical interventions against infectious diseases. Despite the proven efficacy and safety profiles of coronavirus disease 2019 (COVID-19) vaccines, there are still a substantial number of people who express vaccine hesitancy. Factors that influence vaccine decision-making are heterogenous, complex, and context specific and may be caused or amplified by uncontrolled online information or misinformation. With respect to COVID-19, the recent emergence of novel variants of concern that give rise to milder disease also drives vaccine hesitancy. Healthcare professionals remain one of the most trusted groups to advise and provide information to those ambivalent about COVID-19 vaccination and should be equipped with adequate resources and information as well as practical guidance to empower them to effectively discuss concerns. This article seeks to summarize the currently available information to address the most common concerns regarding COVID-19 vaccination. BioExcel Publishing Ltd 2022-06-20 /pmc/articles/PMC9225513/ /pubmed/35814493 http://dx.doi.org/10.7573/dic.2021-12-3 Text en Copyright © 2022 Kassianos G, Puig-Barberà J, Dinse H, Teufel M, Türeci Ö, Pather S https://creativecommons.org/licenses/by-nc-nd/4.0/Published by Drugs in Context under Creative Commons License Deed CC BY NC ND 4.0, which allows anyone to copy, distribute and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.
spellingShingle Review
Kassianos, George
Puig-Barberà, Joan
Dinse, Hannah
Teufel, Martin
Türeci, Özlem
Pather, Shanti
Addressing COVID-19 vaccine hesitancy
title Addressing COVID-19 vaccine hesitancy
title_full Addressing COVID-19 vaccine hesitancy
title_fullStr Addressing COVID-19 vaccine hesitancy
title_full_unstemmed Addressing COVID-19 vaccine hesitancy
title_short Addressing COVID-19 vaccine hesitancy
title_sort addressing covid-19 vaccine hesitancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225513/
https://www.ncbi.nlm.nih.gov/pubmed/35814493
http://dx.doi.org/10.7573/dic.2021-12-3
work_keys_str_mv AT kassianosgeorge addressingcovid19vaccinehesitancy
AT puigbarberajoan addressingcovid19vaccinehesitancy
AT dinsehannah addressingcovid19vaccinehesitancy
AT teufelmartin addressingcovid19vaccinehesitancy
AT tureciozlem addressingcovid19vaccinehesitancy
AT pathershanti addressingcovid19vaccinehesitancy